- U.S. Lifts Pause, Will Restart J&J Vaccinations with Warning (nationalreview.com)FDA, CDC Decide Benefits of J&J Vaccine Outweigh the Risks (biospace.com)
The United States will resume Johnson & Johnson COVID-19 vaccinations after health officials lifted an 11-day pause on the shots at the recommendation of a Centers for Disease Control and Prevention advisory panel...The panel voted 10 to 4 to recommend restarting the vaccinations, saying the benefits of the shot outweigh the rare risk of blood clots. However, the group suggested that the vaccine include a warning about the increased risk of the very rare but severe blood clots...READ MORE
- New Bill Would Expand Medicare Patients’ Access to Pharmacist Services (pharmacypracticenews.com)
Two U.S. representatives, G.K. Butterfield and David McKinley introduced the Pharmacy and Medically Underserved Area Enhancement Act, which would provide reimbursement to pharmacists who deliver Medicare Part B services that are already authorized by their respective state laws...“Under this bill, Medicare will pay pharmacists at 85% of the Physician Fee Schedule,” explained Tom Kraus, the vice president of government relations at ASHP. “This is an important step to improve access to care for Medicare beneficiaries and helps ensure that serving these patients will be financially sustainable.”...READ MORE
- Nevada State Board of Pharmacy Newsletter April 2021 (bop.nv.gov)
- Electronic Prescribing Mandate for Controlled Substances
- National Pharmacy Compliance News
- Guidelines, Materials Available to Health Care Providers for Safely Administering COVID-19 Vaccines
- FDA Issues Guidance to Protect Consumers From Methanol Poisoning
- Standardize Concentrations for Oral Liquid Preparations
- Opioid Use Disorder Educational Programs, Resources Available for Pharmacists
- National Diabetes Prevention Program – How Pharmacists Can Get Involved
- Surgery Patients Receive More Opioids in the US Than in Other Countries
- Study Finds 94% Drop in Symptomatic COVID-19 Cases With Pfizer’s Vaccine
- NABP Executive Director/Secretary Addresses Pharmacists’ Involvement in COVID-19 Vaccination During FIP Webinar
- More therapeutics but no surge in vaccine for Michigan, Biden administration says (reuters.com)Michigan Governor Says COVID-19 Infections Could Be Dropping (usnews.com)
The White House said on Monday it was prepared to send additional therapeutic treatments to the state of Michigan, which is experiencing a worrying number of COVID-19 cases, but declined to promise more vaccine as the state has sought...White House coronavirus adviser Andy Slavitt told reporters the U.S. government would work to ensure that states such as Michigan were ordering the full amount of vaccine that was available to them but said that shifting distribution was not in line with the administration’s public health strategy...READ MORE
- Las Vegas man pleads guilty to bilking Medicaid out of $13M (reviewjournal.com)
A Las Vegas man has pleaded guilty to bilking North Carolina Medicaid out of $13 million, prompting the forfeiture of an airplane, a sports car, a pickup, land and luxury jewelry...Timothy Harron, 52, has pleaded guilty to conspiracy to commit health care fraud, wire fraud, money laundering, and aggravated identity theft. Authorities said the guilty plea requires him to forfeit cash and luxury items...READ MORE
- FDA orders shutdown at Emergent’s troubled plant 2 weeks after handing J&J the keys (fiercepharma.com)
Johnson & Johnson’s takeover of COVID-19 vaccine manufacturing at an error-prone Emergent BioSolutions plant in Baltimore didn’t last long...Two weeks after the U.S. stepped in and handed control of vaccine manufacturing at the plant to J&J, Emergent agreed to temporarily halt producing new drug substance there...READ MORE
- Speak up, docs: Bayer’s ‘AMI’ voice assistant talks prescription drug info for physicians (fiercepharma.com)
AMI, pronounced as Amy, is Bayer's new voice assistant and chatbot that can talk to physicians about prescription drugs when they say, “Hey Google, talk to Bayer Pharmaceutical” on Google Home...An acronym for assistant for medical information, AMI is meant to offer quick, hands-free and on-demand information for busy healthcare professionals. Doctors can ask about prescribing information and other details for two oncology drugs, Nubeqa and Xofigo, and three women’s health products, Mirena, Kyleena and Skyla...Bayer is the first pharma to use voice technology to access medical information through Google Home and Google Assistant...READ MORE
- Johnson & Johnson says it has negotiated Covid-19 vaccine warning label with FDA (msn.com)
Johnson & Johnson said Friday that it has negotiated a warning label for its Covid-19 vaccine to make health care providers aware of a potentially increased risk of rare but severe blood clots and low platelet counts...The vaccine maker revealed the warning text, which it said the Food and Drug Administration had agreed to, during a presentation Friday before a Centers for Disease Control and Prevention vaccine advisory panel...Neither the FDA nor CDC has said they will adopt a warning label...READ MORE
- COVID-19 Pandemic Causes Dramatic Shifts in Prescription Drug Spending (pharmacypracticenews.com)
The COVID-19 pandemic heavily influenced U.S. spending for prescription drugs in 2020, according to ASHP's National Trends in Prescription Drug Expenditures and Projections for 2021...Shifts in care related to the pandemic will be a significant driver of drug expenditures in 2021, along with uptake in the use of biosimilars, a large pipeline of new cancer drugs and increased approvals of specialty medications...Prescription drug spending in 2020 grew at a moderate rate of 4.9% to $535.3 billion. Increased use drove the growth, which accounted for 2.9% of the total increase, according to the report. Spending on new drugs accounted for 1.8% of the increase, and price changes accounted for 0.3%...READ MORE
- With less demand for surgical relief during pandemic, Sun cuts poppy production in Tasmania (fiercepharma.com)
For many, the sedative power of poppies was introduced by Dorothy in the Wizard of Oz, galloping through flowers before falling fast asleep...Those blooms now provide raw materials for opioid painkillers used by the millions worldwide. But like the Wicked Witch of the West, who cast that poppy spell on Dorothy, the coronavirus pandemic has put a sleeper hold on the production of poppies for pharmaceutical use...The global demand for opium-based products plummeted last year as COVID forced the cancellation of most elective surgeries, and now, that diminished need for surgical pain relief products has forced Sun Pharma of India to reduce its number of contracted poppy growers in Tasmania and to eliminate two of its field officers...READ MORE